ORIGINAL RESEARCHInternational Recommendations to Manage Poststroke Equinovarus Foot Deformity Validated by a Panel of Experts Using Delphi
Section snippets
Methods
This study used a Delphi process, which is a rigorous approach to define consensus when evidence is lacking.13,14
The questionnaire evolved over the course of the 3 rounds (supplemental appendix S1, available online only at http://www.archives-pmr.org). After obtaining answers from the first questionnaire (supplemental appendix S2, available online only at http://www.archives-pmr.org), members from the steering committee wrote a second questionnaire that had questions deleted, reformulated, or
Results
Results are presented following the usual process for the management of EVF.
Discussion
Currently, no international recommendations exist describing the management of EVF in patients with spastic paresis hemiplegia after stroke and/or after central nervous system injury. Since the first international Symposium of Neuro-Orthopedics in Versailles (2017), the experts in the field of neuro-orthopedic have been gathered together biannually to share the knowledge of their clinical experience across disciplines. From this collaboration, we embarked on creating recommendations for the
Conclusions
This study was performed to address the absence of recommendations for the management of EVF. We developed these first guidelines using a Delphi process to provide unanimity on the process of diagnosing, assessing, and treating EVF. The establishment and dissemination of this information to physicians, specialists, and nonspecialists should make it possible to direct these specific patients to a network of experts to optimize patient functional recovery and improve their autonomy to facilitate
Acknowledgment
We thank Oscar Haigh for the English corrections.
References (26)
- et al.
[Epidemiology of pes varus and/or equinus one year after a first cerebral hemisphere stroke: apropos of a cohort of 86 patients] [French]
Ann Readaptation Med Phys
(2004) - et al.
Global estimates of the need for rehabilitation based on the Global Burden of Disease Study 2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet
(2021) - et al.
Neuro-orthopedic surgery for equinovarus foot deformity in adults: a narrative review
J Foot Ankle Surg
(2022) - et al.
Orthopaedic surgery for patients with central nervous system lesions: concepts and techniques
Ann Phys Rehabil Med
(2019) The management of spastic equinovarus deformity following stroke and head injury
Foot Ankle Clin
(2011)- et al.
Muscle overactivity in the upper motor neuron syndrome: conceptualizing a treatment plan and establishing meaningful goals
Phys Med Rehabil Clin N Am
(2018) - et al.
French clinical guidelines for peripheral motor nerve blocks in a PRM setting
Ann Phys Rehabil Med
(2019) - et al.
Comparison between tibial nerve block with anaesthetics and neurotomy in hemiplegic adults with spastic equinovarus foot
Ann Phys Rehabil Med
(2015) - et al.
Percutaneous needle tenotomy for the treatment of muscle and tendon contractures in adults with brain damage: results and complications
Arch Phys Med Rehabil
(2017) - et al.
Minimally invasive soft tissue release of foot and ankle contracture secondary to stroke
J Foot Ankle Surg
(2014)
Can toe-walking contribute to stiff-legged gait?
Am J Phys Med Rehabil
Postoperative adverse outcomes in intellectually disabled surgical patients: a nationwide population-based study
PloS One
The impact of instrumented gait analysis on surgical planning: treatment of spastic equinovarus deformity of the foot and ankle
Foot Ankle Int
Cited by (7)
Exoskeleton-assisted walking rehabilitation for spinal cord injury: CiteSpace analysis of research hotspots
2024, Chinese Journal of Tissue Engineering ResearchAnatomical landmarks for ultrasound-guided rectus femoris diagnostic nerve block in post-stroke spasticity
2023, Australasian Journal of Ultrasound in MedicineValidity and reliability of selective control of upper extremity scale (SCUES) in patients with chronic stroke
2023, Disability and Rehabilitation
Supported by Allergan, an AbbVie company. The authors acknowledge Orpea-Clinea and Lagarrigue SA for providing funding to support the realization of the study.
Disclosures: A.P. received unrelated funding from Allergan-Abbvie, Ipsen, and Merz. N.S.N. received unrelated funding from Ipsen. P.R. received unrelated funding from Abbott, Boston Scientific, Medtronic, Allergan-Abbvie, Ipsen, and Merz. S.C. received unrelated funding from Merz, Allergan-Abbvie, Ipsen, Almirall, Roche, Biogen, and Medtronic. T.D. received unrelated funding from Abbvie, IPSEN, and Merz. The other authors have no additional disclosures.